Department of Nutritional Sciences, School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom.
Division of Women's, Children's and Clinical Support, Imperial College Healthcare NHS Trust, London, United Kingdom.
J Nutr. 2021 Oct 1;151(10):3137-3150. doi: 10.1093/jn/nxab209.
Vitamin D concentrations are a function of sunlight exposure and dietary intake. However, current dietary vitamin D recommendations do not consider differences in country-specific sunlight availability or spontaneous individual exposure.
We aimed to investigate the effects of vitamin D supplementation and sunlight exposure on vitamin D concentrations in Brazilian women living in high compared with low latitudes.
In 2 parallel, double-blind, randomized placebo-controlled trials, Brazilian women living in England (51°N) composed "without ultraviolet B (UVB) exposure" groups and those living in Brazil (16°S) composed the "with UVB exposure" groups (mean age, 31.39 ± 8.7 years). Participants received 15 μg cholecalciferol or placebo daily for 12 weeks during wintertime. Serum 25-hydroxyvitamin D [25(OH)D] concentrations, the primary outcome, were assessed by HPLC-MS/MS, vitamin D intakes were assessed by 4-day diet diaries, and sunlight exposure was assessed by UVB dosimeters. The effects of supplementation and UVB exposure were tested by the intention to treat with a linear mixed model.
The 25(OH)D concentrations increased in both supplemented groups [from 75.1 ± 22.0 to 84.8 ± 21.0 nmol/L (P = 0.004) in the group with UVB exposure; from 38.1 ± 15.9 to 55.1 ± 12.2 nmol/L (P < 0.001) in the group without UVB exposure], with no significant changes in either placebo group. Concentrations in both supplemented groups were higher than those in the placebo group without UVB exposure (P = 0.0002 in the group with UVB exposure; P = 0.0035 in the group without UVB exposure). Postintervention 25(OH)D concentrations were significantly affected by serum 25(OH)D concentrations at baseline (P < 0.0001) and by intervention (placebo or supplement; P > 0.0001), with a large effect size (Cohen's D = 0.768), but were not affected by UVB exposure (with or without; P = 0.1386), nor by the interaction between the intervention (placebo or supplement) and UVB exposure (with or without; P = 0.9845).
Moderate supplementation of 15 ug/d cholecalciferol, in accordance with current recommendations, supports an adequate vitamin D status in adult women, irrespective of latitude, and might concomitantly prevent an increase in parathyroid hormone. The Interaction Between Vitamin D Supplementation and Sunlight Exposure in Women Living in Opposite Latitudes (D-SOL) study was registered at clinicaltrials.gov as NCT03318029.
维生素 D 浓度是阳光暴露和饮食摄入的函数。然而,目前的膳食维生素 D 推荐量并没有考虑到特定国家阳光可获得性的差异或个体自发暴露的差异。
我们旨在研究维生素 D 补充和阳光暴露对生活在高纬度和低纬度的巴西女性维生素 D 浓度的影响。
在 2 项平行、双盲、随机安慰剂对照试验中,居住在英国(51°N)的巴西女性组成“无紫外线 B(UVB)暴露”组,居住在巴西(16°S)的女性组成“有 UVB 暴露”组(平均年龄 31.39±8.7 岁)。参与者在冬季每天接受 15μg 胆钙化醇或安慰剂治疗 12 周。血清 25-羟维生素 D [25(OH)D]浓度是主要观察指标,采用 HPLC-MS/MS 进行评估,维生素 D 摄入量采用 4 天饮食日记进行评估,阳光暴露采用 UVB 剂量计进行评估。通过意向治疗线性混合模型来检验补充和 UVB 暴露的效果。
两组补充组的 25(OH)D 浓度均升高[有 UVB 暴露组从 75.1±22.0 增加到 84.8±21.0 nmol/L(P=0.004);无 UVB 暴露组从 38.1±15.9 增加到 55.1±12.2 nmol/L(P<0.001)],而安慰剂组无明显变化。两组补充组的浓度均高于无 UVB 暴露的安慰剂组(有 UVB 暴露组 P=0.0002;无 UVB 暴露组 P=0.0035)。干预后 25(OH)D 浓度显著受基线时血清 25(OH)D 浓度(P<0.0001)和干预(安慰剂或补充剂;P>0.0001)的影响,具有较大的效应量(Cohen's D=0.768),但不受 UVB 暴露(有或无;P=0.1386)或干预(安慰剂或补充剂)与 UVB 暴露(有或无;P=0.9845)之间的相互作用影响。
根据目前的建议,每天补充 15μg 胆钙化醇可以适度补充维生素 D,使成年女性的维生素 D 状态保持充足,而与纬度无关,并且可能同时预防甲状旁腺激素的增加。生活在相反纬度的女性中维生素 D 补充和阳光暴露的相互作用(D-SOL)研究在 clinicaltrials.gov 上注册为 NCT03318029。